FSLR
58
-3
EQT
60
4
PDCO
60
2
KMB
53
2
MCK
55
2
AAP
33
-2
MET
53
2
ZION
55
2
CFG
48
6
KMI
48
-2
WRK
59
3
BEN
50
-6
COP
56
-6
VMC
68
-3
GPC
61
-3
NRG
77
3
GT
50
-2
DVN
44
-3
WFC
58
-3
AES
55
15
FSLR
58
-3
EQT
60
4
PDCO
60
2
KMB
53
2
MCK
55
2
AAP
33
-2
MET
53
2
ZION
55
2
CFG
48
6
KMI
48
-2
WRK
59
3
BEN
50
-6
COP
56
-6
VMC
68
-3
GPC
61
-3
NRG
77
3
GT
50
-2
DVN
44
-3
WFC
58
-3
AES
55
15
Financhill
Back

Catalyst Pharmaceuticals Vs. Oncternal Therapeutics Industry Stock Comparison

Sell
46

CPRX
Catalyst Pharmaceuticals

Last Price:
14.79
Seasonality Move:
2.11%
Sell
40

ONCT
Oncternal Therapeutics

Last Price:
8.60
Seasonality Move:
0.33%
Sell
46
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $15.12. The Score for CPRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Oncternal Therapeutics (ONCT) is a Sell

Is Oncternal Therapeutics a Buy, Sell or Hold?

  • The current Oncternal Therapeutics [ONCT] share price is $8.55. The Score for ONCT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ONCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $15.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ONCT Stock Price Chart

What is Oncternal Therapeutics's stock price today?

  • The Oncternal Therapeutics share price today is $8.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ONCT is experiencing selling pressure, which indicates risk of future bearish movement.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 45.75 Sell
Chaikin Money Flow: 672436 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.13 - 16.11) Sell
Bollinger Bands (100): (14.04 - 16.2) Sell

ONCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 46.96 Sell
Chaikin Money Flow: -1346 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.3 - 9.1) Sell
Bollinger Bands (100): (7.66 - 9.94) Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.29 Sell
20-day SMA: 15.48 Sell
50-day SMA: 15.44 Sell
200-day SMA: 14.19 Buy
8-day EMA: 15.22 Sell
20-day EMA: 15.43 Sell
50-day EMA: 15.37 Sell
200-day EMA: 14.58 Buy

ONCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.72 Sell
20-day SMA: 8.84 Sell
50-day SMA: 8.88 Sell
200-day SMA: 7.78 Buy
8-day EMA: 8.71 Sell
20-day EMA: 8.75 Sell
50-day EMA: 8.77 Sell
200-day EMA: 9.17 Sell

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.

Oncternal Therapeutics Earnings Growth & ONCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.73 per share, and a decrease next year of $0.56 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oncternal Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):